Beroni Group is a globalized company integrating research and development (R&D), production and marketing, with world-class management team and scientist team and capability to become a leading global player in biopharmaceutical sector. It currently has four core businesses - research and development of new drugs and clinical trial, precise diagnosis and immunotherapy for cancer treatment, diagnosis of infectious diseases, and e-commerce platform for sales of pharmaceutical, healthcare and cosmetic products. Beroni Group was listed on National Stock Exchange of Australia (NSX) on 12th May 2017 and began trading on OTCQX in US market on 29th April 2019. It is the first company from National Stock Exchange of Australia to be traded on OTCQX.